Brain oxidative stress as basic target of antioxidant traditional oriental medicines

Neurochemical Research

Volumn 34, Issue 4, 2009, Pages 711-716

  Konishi, Tetsuya ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Cerebral oxidative damage; Herbal antioxidant synergism; Ischemia reperfusion; Mibyou (sub healthy condition); Psychological stress; Qizhu Tang; Schisandra chinensis; Shengmai San; Whiskers cut stress model

Indexed keywords

ANTIOXIDANT; CHOUTO SAN; HERBACEOUS AGENT; KAMPO; KEISHIBUKURYOUGANKA YOKUININ; REIKEIJUTSUKAN TO; SHENGMAI SAN; UNCLASSIFIED DRUG; ZOKUMEITO;

ANTIOXIDANT ACTIVITY; BRAIN; BRAIN DISEASE; DISTRESS SYNDROME; DRUG EFFECT; GINSENG; HEALTH STATUS; HERBAL MEDICINE; ISCHEMIA; MIBYOU; NONHUMAN; OPHIOPOGON JAPONICUS; OXIDATIVE STRESS; PRESCRIPTION; PRIORITY JOURNAL; REPERFUSION INJURY; SCHISANDRA CHINENSIS; SHORT SURVEY; TRADITIONAL MEDICINE;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN ISCHEMIA; DRUG COMBINATIONS; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MEDICINE, KAMPO; OXIDATIVE STRESS; REPERFUSION INJURY; STRESS, PSYCHOLOGICAL;

MUS; OPHIOPOGON JAPONICUS; PANAX GINSENG; SCHISANDRA CHINENSIS;

EID: 62349106799     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9872-9     Document Type: Short Survey

References (50)

1. B Halliwell JMC Guteridge 1985 Oxygnen toxicity, oxygen radicals, transition metals, and disease Biochem J 21 1 14
2. JK Liu A Mori 1999 Stress, aging, brain oxidative damage Neurochem Res 24 1479 1497 10.1023/A:1022597010078
3. A Nunomura RJ Castellani X Zhu PI Moreira G Perry MA Smith 2006 Involvement of oxidative stress in Alzheimer disease J Neuropathol Exp Neurol 65 631 641 10.1097/01.jnen.0000228136.58062.bf
4. PM Kidd 2008 Alzheimer disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention Altern Med Rev 13 85 115
5. M Ebadi S Sharma 2006 Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease Exp Biol Med 231 1576 1583
6. SR Danielson K Andersen 2008 Oxidative and nitrative protein modifications in Parkinson's disease Free Radic Biol Med 44 1787 1794 10.1016/j.freeradbiomed.2008.03.005
7. M Fujimura T Tominaga PH Chan 2005 Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis Neurocrit Care 2 59 66 10.1385/NCC:2:1:059
8. P Mecocci E Mariani V Cornacchiola MC Polidori 2004 Antioxidants for the treatment of mild cognitive impairment Neurol Res 26 598 602 10.1179/016164104225017659
9. P Kooncumchoo S Sharma J Porter P Govitrapong M Ebadi 2006 Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons J Mol Neurosci 28 125 142 10.1385/JMN:28:2:125
10. O Gonzalez-Perez NA Moy-Lopez J Guzman-Muniz 2008 Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine Rev Invest Clin 60 58 67
11. X Wei Z Ma CV Fontanilla 2008 Caffeic acid phenethyl ester prevents cerebeller granule neurons (CGNs) against glutamate-induced neruotoxicity Neuroscience 155 1098 1105 10.1016/j.neuroscience.2008.06.056
12. R Bordet D Deplanque P Maboudou F Puisieux 2000 Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide- induced brain ischemic tolerance J Cereb Blood Flow Metab 20 1190 1196 10.1097/00004647-200008000-00004
13. M Seif-El-Nasr AS Atia RM Abdelsalam 2008 Effect MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant Azrneimittelforschung 58 160 167
14. T Watanabe M Tahara S Todo 2008 The novel antioxidant edaravone; from bench to bedside Cardiovasc Ther 26 101 114 10.1111/j.1527-3466.2008.00041.x
15. R Miyamoto S Shimakawa S Suzuki T Ogihara H Tamai 2008 Edaravone prevents kainic acid-induced neuronal death Brain Res 1209 85 91 10.1016/j.brainres. 2008.02.064
16. JN Chacon MR Chedekel EJ Land TG Truscott 1987 Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4- phenylpyridinium ion Biochem Biophys Res Commun 144 957 964 10.1016/S0006- 291X(87)80057-8
17. B Halliwell JMC Gutteridge 1985 Oxygen radicals and the nervous system Trends Neurosci 8 22 26 10.1016/0166-2236(85)90010-4
18. M Ebadi S Sharma 2003 Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease Antioxid Redox Signal 5 319 335 10.1089/152308603322110896
19. P Bubber V Haroutunian G Fisch 2005 Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Ann Neurol 57 695 703 10.1002/ana.20474
20. M Plaas A Karis J Innos 2008 Alpha-synuclein A30P point-mutaiton generates age-dependent nigrostariatal deficiency in mice J Physiol Pharmacol 59 205 216
21. CC Chiueh T Andoh AR Lai E Lai G Krishna 2000 Neuroprotective strategies in Parkinson's disease: protection against progression nigral damage induced by free radical Neurotox Res 2 293 310
22. JT Cheng 2000 Drug therapy in Chinese traditional medicine J Clin Pharmacol 40 445 450 10.1177/00912700022009198
23. Zhang E (ed) (1988) Basic theory of traditional Chinese medicine. Publishing House of Shanghai University of Traditional Chinese Medicine, China
24. T Konishi H Ichikawa H Nishida XJ Wang 2006
25. B Ou D Huang M Hampsch-woodill JA Flanagan 2003 When east meets west: the relationship between yin-yang and antioxidation-oxidation FASB J 17 127 129 10.1096/fj.02-0527hyp
26. M Adams F Gmunder M Hamburger 2007 Plants traditionally used in age related brain disorders-A survey of ethnobotanical literature J Ethnopharmacol 113 363 381 10.1016/j.jep.2007.07.016
27. K Iwasaki T Satoh-Nakagawa M maruyama 2005 A Randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral an psychological symptoms and activities of daily living in dementia patients J Clin Psychiatry 66 248 252
28. 3-induced Epilepsy Free Radic Biol Med 9 451 454 10.1016/0891-5849(90)90023-C
29. SM Liang SY Chen SQ Kian 2002
30. XJ Wang H Ichikawa T Konishi 2001 Antioxidant potential of Qizhu Tang, a Chinese herbal medicine, and the effect on cerebral oxidative damage after ischemia-reperfusion in rat Biol Pharm Bull 24 558 563 10.1248/bpb.24.159
31. RS Kraus R Pasieczny K Lariosa-Willingham 2005 Antioxidant properties of minocyclin; neuroprotection in an oxidative stress assay and direct radical-scavenging assay J Neurochem 94 819 827 10.1111/j.1471-4159.2005.03219.x
32. WD Rausch S Liu G Gille K Radad 2006 Neuroprotective effects of ginsenosides Acta Neurobiol Exp (Warsz) 66 369 375
33. SY Tang M Whiteman ZF Peng A Jenner EL Young B Halliwell 2004 Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional Chinese medicines Free Radic Biol Med 36 1575 1587 10.1016/j.freeradbiomed.2004.03.017
34. XJ Wang T Magara T Konishi 1999 Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, Shengmai San, in rats Free Radic Res 31 449 455 10.1080/10715769900301011
35. H Ichikawa T Konishi 2002 In vitro antioxidant potentials of traditional Chinese medicine, Shengmai San and their relation to in vivo protective effect on cerebral oxidative damage in rats Biol Pharm Bull 25 898 903 10.1248/bpb.25.898
36. HJ Ichikawa h Wang T Konishi 2002 Role of component herbs in antioxidant activity of Shengmai San, a traditional Chinese medicine formula preventing cerebral oxidative damage in rat Am J Chin Med 31 509 521
37. L Wang H Nishida Y Ogawa T Konishi 2003 Prevention of oxidative injury in PC12 cells by a traditional Chinese medicine, Shengmai San, as a model of an antioxidant-based composite formula Biol Pharm Bull 26 1000 1004 10.1248/bpb.26.1000
38. H Ichikawa L Wang T Konishi 2006 Prevention of Cerebral Oxidative Injury by Post-ischemic Intravenous Administration of Shengmai San Am J Chin Med 34 591 600 10.1142/S0192415X06004120
39. Konishi T, Li YJ, Nishida H, Gong M (2005) Modulation of antioxidant gene expression by TCM in mentally stressed mice as a model of sub-healthy condition. MEDIMOND Int Proc of ISNA & SFRR, Asia, pp 79-85
40. T Motoshima S Sato T Konishi 2007 The effect of Zokumei-to on cerebral oxidative stress model in rats and mice Pharmacometrics 72 57 62
41. N Chen PY Chu KM Ko 2008 Schisandrin B enhances cerebral mitochondrial antioxidant status and structural integrity, and protects against cerebral ischemia/reperfusion injury in rats Biol Pharm Bull 31 1387 1391 10.1248/bpb.31.1387
42. YJ Li M Gong T Konishi 2007 Antioxidant Synergism among Component Herbs of Traditional Chinese Medicine Hormula, Shengmai San Studied in vitro and in vivo J Health Sci 53 692 699 10.1248/jhs.53.692
43. Q Wang 2001 Traditional Chinese medicine will make new contributions to mankind in treating sub-healthy conditions in the 21 century J Beijing Univ TCM 24 1 4
44. BD Bultz LE Carlson 2005 Emotional distress: the sixth vital sign in cancer care J Clin Oncol 23 6440 6441 10.1200/JCO.2005.02.3259
45. JK Liu XY Wang MK Shigenaga HC Yeo A Mori 1996 Immobilization stress causes oxidative damage to lipid, protein, and DNA in the brain of rat FASEB J 10 1532 1538
46. L Wang G Muxin H Nishida C Shirakawa S Sato T Konishi 2006 Psychological stress-induced oxidative stress as a model of sub-healthy condition and the effect of TCM eCAM 4 195 202
47. SK Talwar S Xu ES Hawley S Weiss KA Moxon JK Chapin 2002 Rat navigation guided by remote control Nature 417 37 38 10.1038/417037a
48. MM Rahman T Ichiyanagi T Komiyama S Sato T Konishi 2008 Effects of anthocyanins on psychological stress-induced oxidative stress and neurotransmitter status J Agric Food Chem 56 7545 7550
49. H Nishida M Kushida Y Nakajima Y Ogawa N Tatewaki T Konishi 2007 Amyloid-b-induced cytotoxicity of PC-12 cell was attenuated by Shengmai San through redox regulation and outgrowth induction J Pharmacol Sci 104 73 81 10.1254/jphs.FP0070100
50. NL Wang YL Liou MT Lin CL Lin CK Chang 2005 Chinese herbal medicine, Shengmai San, is effective for improving circulatory shock and oxidative damage in the brain during heatstroke J Pharmacol Sci 97 253 265 10.1254/jphs.FP0040793